Regular MRI vs after a glucose injectionWeizmann Institute of Science Pancreatic cancer is difficult to detect, in part because the pancreas sits deep in the abdominal cavity in a position that can ...

It is possible to use magnetic resonance imaging to 'see' the inflammation in the pancreas that leads to type 1 diabetes, a pilot study has revealed. Autoimmunity and inflammation directed against the ...

"MRI is invaluable for diagnosing and monitoring many pancreatic disorders including chronic and acute pancreatitis, non-alcoholic fatty pancreas disease and pancreatic cancer," said VUMC site ...

A magnetic resonance imaging (MRI)-based screening program for individuals at high risk of pancreatic cancer identified pancreatic lesions in 16 of 40 (40 percent) of patients, of whom five underwent ...

MRI-based screening in patients older than 50 years with new-onset or deteriorating diabetes detected stage IB pancreatic cancer in a patient with deteriorating diabetes, highlighting the need for ...

"We expect to complete patient enrollment in our Phase 3 clinical trial this year and, if successful, file an NDA in 2009." Repligen is currently conducting a Phase 3 clinical trial to evaluate the ...

Please provide your email address to receive an email when new articles are posted on . Ablative MRI-guided radiation therapy prolonged survival compared with standard therapy among patients with ...

MRI could be used to screen for pancreatic cancer in individuals at high risk for the disease, according to early results from a Swedish study, published online on April 8 in JAMA Surgery. The study ...

This technology, developed in collaboration with the Moffitt Cancer Center and Cellular Nanomed, was originally created in the lab of UM professor Sakhrat Khizroev, Ph.D., in collaboration with Ping ...

The overall risk of malignancy in pancreatic cysts may be as low as 0.5 to 1.5%, and the annual risk of progression is 0.5%. 7,15 Conversely, studies estimate that 15% of all pancreatic ...

Tumours growing in organs of different vascular environment could exhibit diverse responses to vascular disrupting agent (VDA). This study was aimed to identify in vivo imaging biomarkers for ...